what could we expect from this ?

[marcet]

email-st.seekingalpha.com/c...

[MBAnderson]

Looks good, but it's an article without specifics, i.e. how much improvement and in which symptoms?

[JayPwP in reply to MBAnderson]

This looks like an investor update. The actual availability of Tavapadon may be years away

[MBAnderson in reply to JayPwP]

10 - considering the speed of the FDA

[JayPwP]

Well... Since you are posting the URL, we are assuming that you have read the contents. We expect a short summary along with the URL

🏃🏃🏃😆😆😆

[MBAnderson in reply to JayPwP]

Summary; The stuff may work for some pwp, altho we're not saying how much.

[JayPwP in reply to MBAnderson]

Thanks Marc. I was responding to the original poster.

[park_bear in reply to JayPwP]

This is just a new dopamine agonist that's all:

"Tavapadon is a selective D1/D5 receptor partial agonist in development for Parkinson's disease"

Link to actual press release:

news.abbvie.com/2024-09-26-...

[JayPwP in reply to park_bear]

Thank you PB